CoChat

Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms

Open access

The DOI matches its Crossref record; 155 of the 156 references it cites were found in a registry or an index.

Abstract

Exercise remains a key component of nonalcoholic fatty liver disease (NAFLD) treatment. The mechanisms that underpin improvements in NAFLD remain the focus of much exploration in our attempt to better understand how exercise benefits patients with NAFLD. In this review, we summarize the available scientific literature in terms of mechanistic studies which explore the role of exercise training in modulating fatty acid metabolism, reducing hepatic inflammation, and improving liver fibrosis. This review highlights that beyond simple energy expenditure, the activation of key receptors and pathways may influence the degree of NAFLD-related improvements with some pathways being sensitive to exercise type, intensity, and volume. Importantly, each therapeutic target of exercise training in this review is also the focus of previous or ongoing drug development studies in patients with nonalcoholic steatohepatitis (NASH), and even when a regulatory-agency-approved drug comes to market, exercise will likely remain an integral component in the clinical management of patients with NAFLD and NASH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu15112452

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Exercise training favorably impacts multiple mechanisms of action important in the development of NAFLD and disease progression to NASH. FFAs, free fatty acids; PPAR-α/γ, peroxisome proliferator-activated receptor alpha/gamma; FGF-21, fibroblast growth factor-21; T3, triiodothyronine; UCP, mitochondrial uncoupling proteins; AMPK, adenosine monophosphate-activated protein kinase; ROS, reactive oxygen species; ASK, apoptosis signal-regulating kinase; FXR, farnesoid X receptor; GLP-1, glucagon-like peptide 1; PAMPS, pathogen-associated molecular patterns; GLUT-4, glucose transporter type 4. Created with BioRender.com.
Figure 1 Exercise training favorably impacts multiple mechanisms of action important in the development of NAFLD and disease progression to NASH. FFAs, free fatty acids; PPAR-α/γ, peroxisome proliferator-activated receptor alpha/gamma; FGF-21, fibroblast growth factor-21; T3, triiodothyronine; UCP, mitochondrial uncoupling proteins; AMPK, adenosine monophosphate-activated protein kinase; ROS, reactive oxygen species; ASK, apoptosis signal-regulating kinase; FXR, farnesoid X receptor; GLP-1, glucagon-like peptide 1; PAMPS, pathogen-associated molecular patterns; GLUT-4, glucose transporter type 4. Created with BioRender.com.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Research works printed but not linked: 1

  1. Noureddin, 2022, HU6 reduces liver fat in subjects with high BMI NAFLD: Top-line results from a phase 2a trial, Hepatology, 76, S94

Cited by

See all 26

Metadata

Authors
Heinle, J. W., DiJoseph, K., Sabag, A., Oh, S., Kimball, S. R., Keating, S., & Stine, J. G.
Affiliations
  • Pennsylvania State University (US)
  • The University of Sydney (AU)
  • R Professional University Of Rehabilitation (JP)
  • The University of Queensland (AU)
Corresponding author
Stine, Jonathan G.
Venue
Nutrients
Publisher
MDPI AG
Published
2023-05-24
Volume
15
Issue
11
Pages
2452
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4378229185
Cited by
26
References
156
Citations by year
2026: 6 · 2025: 9 · 2024: 9 · 2023: 2
FWCI
1.01
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (K23DK131290)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
Keywords
exercise training, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, fatty acid metabolism, liver inflammation, liver fibrosis, energy expenditure, exercise intensity and volume, drug development
MeSH terms
Humans, Liver, Liver Cirrhosis, Exercise, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.